Hologic, Inc. (NASDAQ:HOLX) Q4 2024 Earnings Call Transcript November 4, 2024 Hologic, Inc. reports earnings inline with ...

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year ...

Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today's conference is being recorded. All ...

If you’re on the fence about investing in Hologic Inc or Revvity Inc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on ...

Hologic, Inc. focuses on women's health, projecting $4 billion in revenue for 2024. Learn why HOLX stock remains a compelling ...

Citigroup has recently reduced Hologic Inc (HOLX) stock to Neutral rating, as announced on October 1, 2024, according to Finviz. Earlier, on June 27, 2024, Stephens had initiated the stock to ...

Hologic has recalled the Biozorb devices after 188 reports of adverse events in patients who received the implants in breast ...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup.

Hologic (Nasdaq: HOLX) notified the state of Connecticut that it plans to cut 86 jobs at its Danbury, Connecticut facility.

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive ...